Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03162848 · ClinicalTrials.gov registry record · NA
SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure
A NA study, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03162848: Completed NA study, sponsored by University of Missouri, Kansas City.
NCT03162848 is a NA study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03162848, a NA study, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this pilot RCT study is to evaluate the acceptability and feasibility of a SystemCHANGE™ intervention to improve medication adherence in older adults with heart failure. The intervention focuses on changing the individual's environment by incorporating medication taking into existing routines using small experiments with feedback, and receiving support from people who impact routines.
Primary Outcome
open ended questionnaire asking participants about acceptability and feasibility
Interventions
- BEHAVIORAL SystemCHANGE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
What the finished NCT03162848 record still lists
NCT03162848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which SystemCHANGE is the first listed.
NCT03162848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03162848 about?
NCT03162848 is a clinical study titled "SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure". The purpose of this pilot RCT study is to evaluate the acceptability and feasibility of a SystemCHANGE™ intervention to improve medication adherence in older adults with heart failure. The intervention focuses on changing the individual's environment by incorporating medication taking into existing ...
What is the current status of trial NCT03162848?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-09-01. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03162848?
The interventions under investigation include: SystemCHANGE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03162848?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03162848's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI